Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial laser revascularization causes sustained VEGF secretion.

Baron L Hamman1, Cory H White, Edson H K Cheung

  • 1Division of Cardiovascular Surgery, Baylor University Medical Center, Dallas, TX 75226, USA. BHamman@cdm.net

Seminars in Thoracic and Cardiovascular Surgery
|June 13, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypes.

The Journal of clinical investigation·2025
Same author

Type A Aortic Dissection After Thoracic Endovascular Aortic Repair for Type B.

The American journal of cardiology·2024
Same author

When to Decline or Delay Central Repair in Aortic Dissection.

The American journal of cardiology·2024
Same author

Very early life microbiome and metabolome correlates with primary vaccination variability in children.

mSystems·2023
Same author

High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.

Cell chemical biology·2023
Same author

μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping.

Journal of the American Chemical Society·2023

Transmyocardial laser revascularization (TMR) increases vascular endothelial growth factor (VEGF) levels, particularly in the late recovery period. This sustained VEGF elevation may explain TMR

Area of Science:

  • Cardiovascular Surgery
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Transmyocardial laser revascularization (TMR) is a therapeutic option for patients with refractory ischemic angina.
  • The precise mechanisms underlying TMR's efficacy, including its impact on angiogenic factors, require further elucidation.
  • Vascular endothelial growth factor (VEGF) plays a critical role in neovascularization and tissue repair.

Purpose of the Study:

  • To investigate the correlation between carbon dioxide (CO(2)) laser TMR and serum levels of vascular endothelial growth factor (VEGF).
  • To determine if changes in VEGF levels are associated with angina symptom relief and increased vascular density post-TMR.
  • To compare VEGF levels in TMR patients with a control group of non-ischemic patients.

Main Methods:

Related Experiment Videos

  • Serum VEGF levels were measured in 28 patients undergoing TMR for ischemic angina at four time points: preoperative, postoperative, convalescence, and late follow-up.
  • VEGF levels were compared to a control group of 10 non-ischemic thoracotomy patients.
  • Angina class and other clinical outcomes were monitored throughout the study period.

Main Results:

  • A significant reduction in angina class was observed in TMR patients, decreasing from 3.8 to 1.0 at 1-year follow-up (P < 0.01).
  • Serum VEGF levels were elevated during the convalescence and late follow-up periods in TMR patients.
  • In the late period, VEGF levels in TMR patients were significantly higher than in the control group and three times higher than preoperatively.

Conclusions:

  • Sustained elevation of VEGF following CO(2) TMR may contribute to increased local vascular density.
  • The observed increase in VEGF levels provides a potential molecular explanation for the therapeutic benefits of TMR in relieving angina.
  • TMR demonstrates a favorable safety profile with no perioperative mortality in this cohort.